Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002038319 | SCV002317387 | uncertain significance | Autosomal recessive ataxia, Beauce type; Emery-Dreifuss muscular dystrophy 4, autosomal dominant | 2022-08-16 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with SYNE1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1519535). This variant is present in population databases (rs149081144, gnomAD 0.008%). This sequence change replaces aspartic acid, which is acidic and polar, with alanine, which is neutral and non-polar, at codon 4473 of the SYNE1 protein (p.Asp4473Ala). |
Athena Diagnostics | RCV002473351 | SCV002771417 | uncertain significance | not provided | 2022-02-17 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV002473351 | SCV003824666 | uncertain significance | not provided | 2019-05-01 | criteria provided, single submitter | clinical testing |